http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009087467-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d4dc42489d4d5995ea72c0615204738c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f78825599cf01bf6f1227634ee110220
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a39a529613f9cb0ee730a24b5b264f7
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-622
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2869
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
filingDate 2008-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_27d480a906ec42f4ae73d3b4dccbcf2b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f3c774fb42dda5ecd46bd088e59ef75
publicationDate 2009-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2009087467-A2
titleOfInvention Monoclonal antibodies and binding fragments thereof directed to the melanocortin-4 receptor and their use in the treatment of cachexia and related conditions and diseases
abstract Disclosed are monoclonal antibodies, binding fragments, and derivatives thereof directed to the human melanocortin-4 receptor, as well as pharmaceutical compositions including the same, and therapeutic uses, including methods for treating cachexia and related conditions and diseases, using such monoclonal antibodies, binding fragments, derivatives, and pharmaceutical compositions.
priorityDate 2007-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5703220-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0027863-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1167386-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129322018
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3059003
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID41206
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2154
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394200
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57283441
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11245343
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6279
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129169175
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25322948
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400531
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3763
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397263
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID172198
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3034398
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5789
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400530
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396305
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396304
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135957497
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406099
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11218679
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6076
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409524
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11333924
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400532
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226450916
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19649
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397262
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5202
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409525
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395468
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395467
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129339946
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11683
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128812924
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5755
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18609376
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410798
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396092
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID40400
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394001
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394037
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128922443
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2913
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393698
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136256902
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394054
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9848990
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395500
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1134
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128960895

Total number of triples: 83.